GCL
EXAS

Glazer Capital LLC’s Exact Sciences EXAS Stock Holding History

Glazer Capital LLC’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$70K – 502
2025
Q4 		$70K Buy
+1,000
New +$80.3K ﹤0.01% 296

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glazer Capital LLC's EXAS Position: Q1 2026 in Review

Glazer Capital LLC sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,725,000 shares — an estimated $175M sold.

Glazer Capital LLC first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $175M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Glazer Capital LLC reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Glazer Capital LLC sold 1,725,000 Exact Sciences shares in Q1 2026, an estimated $175M.
  • Glazer Capital LLC first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Glazer Capital LLC's Exact Sciences position peaked at $175M in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Glazer Capital LLC's 13F filing for Q1 2026, filed 14 May 2026.